Literature DB >> 19466908

Analgesic effect from Ibuprofen nanoparticles inhaled by male mice.

Andrei A Onischuk1, Tatyana G Tolstikova, Irina V Sorokina, Natalya A Zhukova, Anatoly M Baklanov, Vladimir V Karasev, Olga V Borovkova, Galina G Dultseva, Vladimir V Boldyrev, Vasilii M Fomin.   

Abstract

BACKGROUND: Aerosol lung administration is a convenient way to deliver water-insoluble or poorly soluble drugs, provided that small-sized particles are generated. Here, for the outbred male mice, we show that the pulmonary administration of ibuprofen nanoparticles requires a dose that is three to five orders of magnitude less than that for the orally delivered particles at the same analgesic effect.
METHOD: The aerosol evaporation-condensation generator consisted of a horizontal cylindrical quartz tube with an outer heater. Argon flow was supplied to the inlet and aerosol was formed at the outlet. The particle mean diameter and number concentration varied from 10 to 100 nm and 10(3)-10(7) cm(-)3, respectively. The analgesic action and side pulmonary effects caused by the inhalation of ibuprofen nanoparticles were investigated.
RESULTS: The chemical composition of aerosol particles was shown to be identical with the maternal drug. Using the nose-only exposure chambers, the mice lung deposition efficiency was evaluated as a function of the particle diameter.
CONCLUSIONS: The dose-dependent analgesic effect of aerosolized ibuprofen was studied in comparison with the oral treatment. It was found that the dose for aerosol treatment is three to five orders of magnitude less than that required for oral treatment at the same analgesic effect. Accompanying effects were moderate venous hyperemia and some emphysematous signs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466908     DOI: 10.1089/jamp.2008.0721

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  5 in total

1.  Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains.

Authors:  Giovanni Di Bonaventura; Veronica Lupetti; Simone De Fabritiis; Alessandra Piccirilli; Annamaria Porreca; Marta Di Nicola; Arianna Pompilio
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

2.  Visualization of murine intranasal dosing efficiency using luminescent Francisella tularensis: effect of instillation volume and form of anesthesia.

Authors:  Mark A Miller; Jennifer M Stabenow; Jyothi Parvathareddy; Andrew J Wodowski; Thomas P Fabrizio; Xiaowen R Bina; Lillian Zalduondo; James E Bina
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

3.  Antimicrobial Activity of Ibuprofen against Cystic Fibrosis-Associated Gram-Negative Pathogens.

Authors:  Parth N Shah; Kimberly R Marshall-Batty; Justin A Smolen; Jasur A Tagaev; Qingquan Chen; Christopher A Rodesney; Henry H Le; Vernita D Gordon; David E Greenberg; Carolyn L Cannon
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

4.  Nanoaerosols reduce required effective dose of liposomal levofloxacin against pulmonary murine Francisella tularensis subsp. novicida infection.

Authors:  Crystal N Propst; Albert O Nwabueze; Igor L Kanev; Rachel E Pepin; Bradford W Gutting; Victor N Morozov; Monique L van Hoek
Journal:  J Nanobiotechnology       Date:  2016-04-18       Impact factor: 10.435

5.  Aerosol Inhalation Delivery of Triazavirin in Mice: Outlooks for Advanced Therapy Against Novel Viral Infections.

Authors:  Sergey V Valiulin; Andrey A Onischuk; Sergey N Dubtsov; Anatoly M Baklanov; Sergey V An'kov; Maria E Plokhotnichenko; Tatyana G Tolstikova; Galina G Dultseva; Vladimir L Rusinov; Valery N Charushin; Vasily M Fomin
Journal:  J Pharm Sci       Date:  2020-11-26       Impact factor: 3.534

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.